Skip to content

Influenza Reference

Influenza is an acute respiratory infection caused by influenza viruses. Seasonal epidemics are usually caused by influenza A or B. Infection ranges from mild illness to pneumonia, respiratory failure, sepsis, and death.

The Patuxent Flu Outbreak (2030) spread through the Eligible Persons Program in late 2030 and caused severe complications for several residents.

Transmission and onset

Influenza spreads mainly through respiratory particles produced when an infected person breathes, speaks, coughs, or sneezes. Transmission through hands or objects contaminated with respiratory secretions can also occur. Shared air, close contact, poor ventilation, delayed isolation, and movement between a facility and the surrounding community can accelerate an outbreak.

Symptoms usually begin one to four days after exposure. Adults may transmit the virus before they recognize that they are ill and for several days afterward; severe illness and immunocompromise can prolong viral shedding.

Presentation

Common symptoms include:

  • fever or chills, although influenza can occur without fever;
  • cough, sore throat, or nasal congestion;
  • headache and muscle or body aches;
  • marked fatigue or weakness; and
  • vomiting or diarrhea in some people, especially children.

Symptoms often begin abruptly, but no single pattern distinguishes influenza from every other respiratory infection. Confusion, difficulty breathing, persistent chest pain, severe weakness, dehydration, seizure, bluish or gray skin or lips, or improvement followed by renewed fever and worsening cough can indicate a complication requiring urgent assessment.

Complications and higher-risk groups

Influenza can cause primary viral pneumonia or create conditions for bacterial coinfection, including secondary bacterial pneumonia. Severe illness may also involve respiratory failure, sepsis, myocarditis, encephalopathy, myositis, kidney injury, or worsening of an existing pulmonary, cardiac, neurological, metabolic, or other chronic condition.

Risk of severe complications is higher among young children, adults sixty-five and older, pregnant and recently postpartum people, residents of long-term-care settings, and people with certain chronic illnesses, disabilities, or immune suppression. Chronic lung disease, including COPD, increases the risk of influenza-related exacerbation and respiratory failure. Neurological and neurodevelopmental conditions can increase risk when they affect breathing, airway clearance, swallowing, communication of symptoms, or response to fever and dehydration.

A person without a listed risk factor can still become critically ill. The severity of one episode does not by itself establish a chronic immune deficiency.

Diagnosis and treatment

Clinical assessment considers symptoms, local influenza activity, exposure, vaccination, underlying conditions, and signs of complication. Molecular tests are generally more sensitive than rapid antigen tests. Imaging, cultures, blood tests, oxygen monitoring, or other studies may be needed when pneumonia, sepsis, or another diagnosis is suspected.

Antiviral treatment is most effective when started early, but hospitalized people and those with severe or progressive illness may benefit even when treatment begins later. Oseltamivir is commonly used for hospitalized influenza. Antibiotics do not treat influenza itself; they are used when bacterial coinfection is suspected or confirmed.

Supportive care may include fluids, fever and pain management, oxygen, respiratory support, and treatment of complications. A person’s ordinary medications, sensory needs, mobility, communication, swallowing, and seizure plan remain relevant during acute care.

Prevention and institutional response

Annual vaccination reduces the likelihood of influenza and its complications but does not prevent every infection. Outbreak response in a congregate setting may include symptom surveillance, prompt testing, separation or cohorting of ill residents, cleaner air, masking, hand hygiene, environmental cleaning, antiviral treatment, and antiviral prophylaxis for exposed people when public-health guidance supports it.

Correctional facilities face additional barriers: crowded housing, shared air, limited control over movement, high rates of chronic illness, understaffing, and delays in transport or outside evaluation. Residents may be unable to isolate, obtain fluids, access their ordinary medications, or seek hospital care without institutional approval. These conditions increase transmission and can delay recognition of deterioration; they do not weaken immunity by depriving an adult body of routine pathogen exposure.

Patuxent Flu Outbreak

Ben Keller

Ben Keller developed the most critical illness in the 2030 outbreak. His influenza progressed to right-lower-lobe pneumonia with broader involvement and developing sepsis physiology. Persistent fever, hypotension, tachycardia, altered mental status, and falling oxygen saturation led to hospital transfer, broad-spectrum antibiotics for suspected bacterial pneumonia, oseltamivir, fluids, high-flow nasal oxygen, and intensive-care monitoring with vasopressors held in readiness.

Ben’s autism, chronic migraine, and trauma from restrictive confinement complicated assessment and treatment. Bright light, unexpected touch, monitoring equipment, restraint, and rapid questioning could produce a sensory or trauma response while fever and hypoxia reduced his ability to explain what was wrong. Staff reduced sensory load, explained touch before procedures, and avoided default restraint. He survived after a narrow ICU course and a prolonged recovery.

Victor Amaya

Victor Amaya became ill early in the outbreak. Fever, dehydration, reduced intake, and physiological stress destabilized his post-traumatic seizure disorder and precipitated a seizure cluster that continued after the first rescue medication. He bit his tongue, required emergency transport, and received intravenous fluids and seizure management.

Raymond Holloman

Raymond Holloman had advanced COPD, making the respiratory outbreak particularly dangerous. He remained visibly depleted and continued masking after the institutional requirement relaxed. He recovered from the outbreak; his later death from COPD-related respiratory failure occurred in winter 2039.

Other residents

Malik Turnage, Rafiq Upshaw, and many other residents also became ill. Malik remained with Andre Moore during a contamination-panic spiral despite his own symptoms. Rafiq continued supporting Ray and other residents and recovered with a lingering cough. Andre’s severe obsessive-compulsive disorder intensified while the threat of transmission was real; he used his commissary account to obtain supplies for sick residents while repetitive washing damaged his hands.

Historical context

Influenza pandemics have repeatedly changed public-health practice, including the 1918 pandemic and the 2009 H1N1 pandemic. Viral culture, rapid antigen tests, and later molecular testing improved diagnosis. Vaccines became available during the twentieth century, and neuraminidase inhibitors expanded antiviral treatment in the late 1990s.

Outbreaks in correctional facilities have demonstrated how quickly influenza can move through a confined population and how chronic illness, close living conditions, staff movement, and delayed treatment shape severity. Vaccination, surveillance, rapid diagnosis, and timely antiviral use remain central to prevention and control.

Sources

  • Centers for Disease Control and Prevention. “Chapter 12: Influenza,” ‘’Epidemiology and Prevention of Vaccine-Preventable Diseases’‘.
  • Centers for Disease Control and Prevention. “People at Increased Risk for Flu Complications.”
  • Centers for Disease Control and Prevention. “Infection Prevention and Control Strategies for Seasonal Influenza in Healthcare Settings.”
  • Centers for Disease Control and Prevention. “Influenza Outbreaks at Two Correctional Facilities—Maine, March 2011.”
  • Infectious Diseases Society of America. “2018 Clinical Practice Guidelines for Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza.”
Medical Conditions Infectious Diseases Respiratory Conditions